UKD-18104-83992
3 vaccinations
1 coded response
24 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 957 / CA
- Registered
- 2021-01-11
- Relationship
- Self
- Race
- Other
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-11
Registered in v-safe
-
2021-01-11
Dose 1 — Pfizer-BioNTech
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-16
- 2021-01-17
- 2021-01-20
- 2021-01-25
-
2021-02-01
Dose 2 — Pfizer-BioNTech
-
2021-02-01
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
-
2021-02-02
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to workAdult check-in
-
2021-02-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Muscle or body achesAdult check-in
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-15
- 2021-02-22
- 2021-03-03
- 2021-03-08
- 2021-03-15
- 2021-05-05
- 2021-08-02
-
2021-10-10
Dose 3 — Pfizer-BioNTech
-
2022-02-01
Survey response — 12 months, dose 2MedDRA: Abortion spontaneous, Uterine leiomyoma — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Fibroids and a miscarriageMedDRA releases: 2024-11 · check-in free text available
-
2022-02-01
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-02-04
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-10-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-11 | Pfizer-BioNTech | |
| 2 | 2021-02-01 | Pfizer-BioNTech | |
| 3 | 2021-10-10 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-01 | Successful 2022-02-04 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 11 — 12 months, dose 2
Symptoms: Fibroids and a miscarriage
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Uterine leiomyoma | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release